Model 1.Charlson Comorbidity Index used as categorical variant. | |||
Factor | HR | 95-% CI | P-value |
CCI = 0 (N = 298) | < 0.001 | ||
CCI = 1–3 (N = 324) | 1.38 | [0.97–1.97] | 0.078 (NS) |
CCI = 4 or more (N = 42) | 6.11 | [3.76–9.92] | < 0.001 |
Gleason score | 1.21 | [1.04–1.41] | 0.015 |
T-grade | 1.11 | [1.01–1.21] | 0.030 |
Zubrod score | 1.63 | [1.29–2.05] | < 0.001 |
Not significant: Androgen deprivation therapy (P = 0.70), age (P = 0.27), N-grade (P = 0.75), PSA-value before diagnosis (P = 0.15). | |||
Model 2.Performance status used as categorical variant. | |||
Z = 0 (N = 348) | < 0.001 | ||
Z = 1 (N = 281) | 2.20 | [1.54–3.13] | < 0.001 |
Z = 2 or more (N = 36) | 2.22 | [1.21–4.09] | 0.010 |
Charlson Comorbidity Index | 1.38 | [1.25–1.51] | < 0.001 |
Gleason score | 1.19 | [1.02–1.39] | 0.026 |
T-grade | 1.11 | [1.02–1.22] | 0.022 |